Share Price and Basic Stock Data
Last Updated: October 17, 2025, 11:24 am
| PEG Ratio | 0.60 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Deepak Chemtex Ltd, operating from Ratnagiri, Maharashtra, has demonstrated a notable trajectory in its revenue streams. For the fiscal year ending March 2025, the company reported sales of ₹68 Cr, marking an increase from ₹50 Cr in March 2024 and ₹46 Cr in March 2023. This upward trend signifies a robust growth strategy, particularly when compared to the previous fiscal years where sales stood at ₹54 Cr in March 2022 and ₹29 Cr in March 2021. The company’s operating profit margin (OPM) also reflected improvement, rising to 19% in FY 2025 from 17% in FY 2024. This performance can be attributed to effective cost management, as expenses increased at a slower rate than sales, moving from ₹42 Cr in March 2024 to ₹55 Cr in March 2025. The quarterly data further supports this trend, with sales of ₹35 Cr reported for March 2025, up from ₹33 Cr in September 2024. Overall, Deepak Chemtex’s revenue growth aligns well with industry expectations, indicating strong operational capabilities.
Profitability and Efficiency Metrics
Deepak Chemtex has consistently improved its profitability metrics, underscored by a net profit of ₹10 Cr in FY 2025, a significant rise from ₹7 Cr in FY 2024 and ₹6 Cr in FY 2023. The earnings per share (EPS) reflected this growth, reaching ₹9.27 for FY 2025, compared to ₹6.10 in FY 2024. The return on equity (ROE) stood at a commendable 22.68% in March 2025, showcasing efficient utilization of equity capital. The company’s interest coverage ratio (ICR) was exceptionally high at 180.40x, indicating that it comfortably meets its interest obligations without any debt burdens, as borrowings were only ₹1 Cr. Additionally, the cash conversion cycle (CCC) improved to 90 days by March 2025, down from 120 days in FY 2024, reflecting better efficiency in managing working capital. The combination of these factors underlines Deepak Chemtex’s strong operational performance and its ability to generate profits effectively.
Balance Sheet Strength and Financial Ratios
Deepak Chemtex’s balance sheet exhibits significant strength, with total assets amounting to ₹64 Cr in March 2025, up from ₹51 Cr in the previous fiscal year. The company maintains a conservative capital structure, as evidenced by a debt-to-equity ratio of just 0.01x, indicating minimal reliance on external borrowings. Reserves have grown substantially to ₹43 Cr, providing a solid buffer for future investments, compared to ₹32 Cr in March 2024. Furthermore, the liquidity position remains strong, with a current ratio of 3.29x and a quick ratio of 2.50x, ensuring ample coverage of short-term liabilities. The price-to-book value (P/BV) ratio stood at 2.16x, suggesting that the stock is trading at a premium relative to its book value. These financial ratios and the overall balance sheet health position Deepak Chemtex favorably against industry peers, enhancing its attractiveness for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Deepak Chemtex Ltd reflects a stable and concentrated ownership structure, with promoters holding 73.05% of the equity as of March 2025. This high promoter stake indicates strong management confidence in the company’s future prospects. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) account for a negligible portion of the ownership, with FIIs holding 0% and DIIs at 1.16%. The public shareholding stands at 26.95%, showcasing a relatively small retail investor base with 907 shareholders as of the latest reporting period. Over the past quarters, the number of shareholders has fluctuated, indicating some volatility in public interest. The absence of institutional investment may suggest a potential risk, as the company might rely heavily on retail investor sentiment, which can be less stable. Nevertheless, the strong promoter holding can act as a stabilizing factor, fostering long-term investor confidence.
Outlook, Risks, and Final Insight
If margins sustain their upward trajectory, Deepak Chemtex could leverage its strong financial position to explore expansion opportunities, potentially enhancing its market share. However, risks remain, including reliance on fluctuating raw material prices and possible regulatory changes that may impact operational costs. Additionally, the limited institutional participation could result in volatility if market conditions shift. On the positive side, the company’s robust profitability metrics and efficient operations position it well for future growth. If the company continues to manage its expenses effectively while driving revenue growth, it may attract more institutional interest, further solidifying its market standing. Overall, maintaining a focus on operational efficiency and navigating potential market challenges will be crucial for sustaining its growth momentum.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Deepak Chemtex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Deepak Chemtex Ltd | 140 Cr. | 129 | 175/89.0 | 13.9 | 49.3 | 0.00 % | 28.1 % | 20.9 % | 10.0 |
| Prolife Industries Ltd | 42.5 Cr. | 104 | 361/104 | 9.08 | 111 | 0.29 % | 14.4 % | 10.8 % | 10.0 |
| Industry Average | 140.00 Cr | 116.50 | 11.49 | 80.15 | 0.15% | 21.25% | 15.85% | 10.00 |
Quarterly Result
| Metric | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 29 | 33 | 35 |
| Expenses | 24 | 26 | 29 |
| Operating Profit | 4 | 7 | 6 |
| OPM % | 15% | 21% | 17% |
| Other Income | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 |
| Profit before tax | 5 | 7 | 7 |
| Tax % | 26% | 24% | 30% |
| Net Profit | 3 | 5 | 5 |
| EPS in Rs | 3.20 | 4.83 | 4.44 |
Last Updated: July 16, 2025, 10:13 am
Below is a detailed analysis of the quarterly data for Deepak Chemtex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2024) to 35.00 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Mar 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Sep 2024) to 29.00 Cr., marking an increase of 3.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Sep 2024) to 6.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Mar 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Sep 2024) to 17.00%, marking a decrease of 4.00%.
- For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 7.00 Cr..
- For Tax %, as of Mar 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Sep 2024) to 30.00%, marking an increase of 6.00%.
- For Net Profit, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 5.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 4.44. The value appears to be declining and may need further review. It has decreased from 4.83 (Sep 2024) to 4.44, marking a decrease of 0.39.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:55 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 29 | 54 | 46 | 50 | 68 |
| Expenses | 25 | 48 | 39 | 42 | 55 |
| Operating Profit | 4 | 6 | 8 | 9 | 13 |
| OPM % | 14% | 12% | 17% | 17% | 19% |
| Other Income | 0 | 0 | 1 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 4 | 6 | 8 | 9 | 14 |
| Tax % | 28% | 26% | 25% | 25% | 27% |
| Net Profit | 3 | 4 | 6 | 7 | 10 |
| EPS in Rs | 6.10 | 9.27 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.33% | 50.00% | 16.67% | 42.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 16.67% | -33.33% | 26.19% |
Deepak Chemtex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
Last Updated: September 5, 2025, 3:11 pm
Balance Sheet
Last Updated: July 25, 2025, 1:28 pm
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 0.50 | 11 | 11 |
| Reserves | 5 | 9 | 15 | 32 | 43 |
| Borrowings | 2 | 2 | 1 | 2 | 1 |
| Other Liabilities | 4 | 6 | 7 | 7 | 10 |
| Total Liabilities | 11 | 17 | 24 | 51 | 64 |
| Fixed Assets | 3 | 3 | 4 | 5 | 6 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 14 | 20 | 46 | 58 |
| Total Assets | 11 | 17 | 24 | 51 | 64 |
Below is a detailed analysis of the balance sheet data for Deepak Chemtex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2024) to 43.00 Cr., marking an increase of 11.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 64.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 12.00 Cr..
- For Total Assets, as of Mar 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (43.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | 2.00 | 4.00 | 7.00 | 7.00 | 12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 65 | 57 | 88 | 110 | 90 |
| Inventory Days | 44 | 21 | 54 | 56 | 51 |
| Days Payable | 65 | 37 | 54 | 46 | 51 |
| Cash Conversion Cycle | 43 | 41 | 88 | 120 | 90 |
| Working Capital Days | 37 | 43 | 81 | 96 | 78 |
| ROCE % | 61% | 58% | 29% | 28% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 100.00 | 100.00 |
| Basic EPS (Rs.) | 11.51 | 6.71 | 7.90 | 5.30 |
| Diluted EPS (Rs.) | 11.51 | 6.71 | 7.90 | 5.30 |
| Cash EPS (Rs.) | 13.49 | 6.28 | 1396.53 | 956.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 50.75 | 38.62 | 3147.07 | 1882.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 50.75 | 38.62 | 3147.07 | 1882.56 |
| Revenue From Operations / Share (Rs.) | 73.13 | 45.43 | 9359.29 | 10843.42 |
| PBDIT / Share (Rs.) | 17.47 | 8.37 | 1835.07 | 1257.31 |
| PBIT / Share (Rs.) | 15.49 | 7.59 | 1703.10 | 1148.55 |
| PBT / Share (Rs.) | 15.39 | 7.56 | 1689.43 | 1129.59 |
| Net Profit / Share (Rs.) | 11.51 | 5.50 | 1264.56 | 847.89 |
| NP After MI And SOA / Share (Rs.) | 11.38 | 5.50 | 1264.56 | 847.89 |
| PBDIT Margin (%) | 23.88 | 18.43 | 19.60 | 11.59 |
| PBIT Margin (%) | 21.18 | 16.70 | 18.19 | 10.59 |
| PBT Margin (%) | 21.05 | 16.63 | 18.05 | 10.41 |
| Net Profit Margin (%) | 15.74 | 12.10 | 13.51 | 7.81 |
| NP After MI And SOA Margin (%) | 15.55 | 12.10 | 13.51 | 7.81 |
| Return on Networth / Equity (%) | 22.41 | 14.23 | 40.20 | 45.08 |
| Return on Capital Employeed (%) | 29.89 | 19.48 | 53.05 | 58.05 |
| Return On Assets (%) | 17.54 | 11.72 | 26.48 | 24.66 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.02 |
| Total Debt / Equity (X) | 0.01 | 0.03 | 0.08 | 0.21 |
| Asset Turnover Ratio (%) | 1.31 | 1.32 | 2.28 | 0.00 |
| Current Ratio (X) | 3.29 | 4.98 | 2.44 | 1.92 |
| Quick Ratio (X) | 2.50 | 4.22 | 1.89 | 1.62 |
| Inventory Turnover Ratio (X) | 8.94 | 5.40 | 8.32 | 0.00 |
| Interest Coverage Ratio (X) | 180.40 | 257.73 | 134.27 | 66.32 |
| Interest Coverage Ratio (Post Tax) (X) | 119.91 | 170.20 | 93.52 | 45.73 |
| Enterprise Value (Cr.) | 114.22 | 53.62 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.44 | 1.09 | 0.00 | 0.00 |
| EV / EBITDA (X) | 6.02 | 5.89 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.50 | 1.45 | 0.00 | 0.00 |
| Price / BV (X) | 2.16 | 1.71 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.50 | 1.45 | 0.00 | 0.00 |
| EarningsYield | 0.10 | 0.08 | 0.00 | 0.00 |
After reviewing the key financial ratios for Deepak Chemtex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 11.51, marking an increase of 4.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 11.51, marking an increase of 4.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.49. This value is within the healthy range. It has increased from 6.28 (Mar 24) to 13.49, marking an increase of 7.21.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.75. It has increased from 38.62 (Mar 24) to 50.75, marking an increase of 12.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 50.75. It has increased from 38.62 (Mar 24) to 50.75, marking an increase of 12.13.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.13. It has increased from 45.43 (Mar 24) to 73.13, marking an increase of 27.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 17.47, marking an increase of 9.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 15.49. This value is within the healthy range. It has increased from 7.59 (Mar 24) to 15.49, marking an increase of 7.90.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 7.56 (Mar 24) to 15.39, marking an increase of 7.83.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.51. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 11.51, marking an increase of 6.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.38. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 11.38, marking an increase of 5.88.
- For PBDIT Margin (%), as of Mar 25, the value is 23.88. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 23.88, marking an increase of 5.45.
- For PBIT Margin (%), as of Mar 25, the value is 21.18. This value exceeds the healthy maximum of 20. It has increased from 16.70 (Mar 24) to 21.18, marking an increase of 4.48.
- For PBT Margin (%), as of Mar 25, the value is 21.05. This value is within the healthy range. It has increased from 16.63 (Mar 24) to 21.05, marking an increase of 4.42.
- For Net Profit Margin (%), as of Mar 25, the value is 15.74. This value exceeds the healthy maximum of 10. It has increased from 12.10 (Mar 24) to 15.74, marking an increase of 3.64.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 12.10 (Mar 24) to 15.55, marking an increase of 3.45.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.41. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 22.41, marking an increase of 8.18.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.89. This value is within the healthy range. It has increased from 19.48 (Mar 24) to 29.89, marking an increase of 10.41.
- For Return On Assets (%), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.72 (Mar 24) to 17.54, marking an increase of 5.82.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has decreased from 1.32 (Mar 24) to 1.31, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has decreased from 4.98 (Mar 24) to 3.29, marking a decrease of 1.69.
- For Quick Ratio (X), as of Mar 25, the value is 2.50. This value exceeds the healthy maximum of 2. It has decreased from 4.22 (Mar 24) to 2.50, marking a decrease of 1.72.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.94. This value exceeds the healthy maximum of 8. It has increased from 5.40 (Mar 24) to 8.94, marking an increase of 3.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 180.40. This value is within the healthy range. It has decreased from 257.73 (Mar 24) to 180.40, marking a decrease of 77.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 119.91. This value is within the healthy range. It has decreased from 170.20 (Mar 24) to 119.91, marking a decrease of 50.29.
- For Enterprise Value (Cr.), as of Mar 25, the value is 114.22. It has increased from 53.62 (Mar 24) to 114.22, marking an increase of 60.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 1.44, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from 5.89 (Mar 24) to 6.02, marking an increase of 0.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.50, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.71 (Mar 24) to 2.16, marking an increase of 0.45.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.50, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.10, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deepak Chemtex Ltd:
- Net Profit Margin: 15.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.89% (Industry Average ROCE: 21.25%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.41% (Industry Average ROE: 15.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 119.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.9 (Industry average Stock P/E: 11.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Aawashi, 28/1A, A/P Adgul Aawashi, Ratnagiri Maharashtra 415722 | saurabh@deepakchemtex.in https://www.deepakchemtex.in/ |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Saurbah Deepak Arora | Chairman & Managing Director |
| Mrs. Trishla Baid | WholeTime Director & CFO |
| Mr. Rajesh Kalikaprasad Tiwari | Executive Director |
| Mr. Narendra Kumar Baid | Non Executive Director |
| Mr. Gautam Lath | Independent Director |
| Mrs. Pinki Kedia | Independent Director |
FAQ
What is the intrinsic value of Deepak Chemtex Ltd?
Deepak Chemtex Ltd's intrinsic value (as of 17 October 2025) is 116.87 which is 9.40% lower the current market price of 129.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 140 Cr. market cap, FY2025-2026 high/low of 175/89.0, reserves of ₹43 Cr, and liabilities of 64 Cr.
What is the Market Cap of Deepak Chemtex Ltd?
The Market Cap of Deepak Chemtex Ltd is 140 Cr..
What is the current Stock Price of Deepak Chemtex Ltd as on 17 October 2025?
The current stock price of Deepak Chemtex Ltd as on 17 October 2025 is 129.
What is the High / Low of Deepak Chemtex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deepak Chemtex Ltd stocks is 175/89.0.
What is the Stock P/E of Deepak Chemtex Ltd?
The Stock P/E of Deepak Chemtex Ltd is 13.9.
What is the Book Value of Deepak Chemtex Ltd?
The Book Value of Deepak Chemtex Ltd is 49.3.
What is the Dividend Yield of Deepak Chemtex Ltd?
The Dividend Yield of Deepak Chemtex Ltd is 0.00 %.
What is the ROCE of Deepak Chemtex Ltd?
The ROCE of Deepak Chemtex Ltd is 28.1 %.
What is the ROE of Deepak Chemtex Ltd?
The ROE of Deepak Chemtex Ltd is 20.9 %.
What is the Face Value of Deepak Chemtex Ltd?
The Face Value of Deepak Chemtex Ltd is 10.0.